Development and assessment of P-32 & Cu64 labelled arabinogalactan for asialoglycoprotein
Development and assessment of P-32 & Cu64 labelled arabinogalactan for asialoglycoprotein receptor directed therapy of hepatocellular carcinoma” (jointly with Manipal Academy of Higher Education, Manipal University), funded by ICMR (Co-PI)